Journal of Drug Targeting

SEP 18, 2026 · JOURNAL ARTICLE

Biointerface-Engineered Gold and Silver Nanoparticles for Skin Cancer Therapy: Linking Nano–Biointerface Design to Therapeutic Function and Clinical Translation

Journal of Drug Targeting

Skin cancer therapy continues to face challenges in achieving selective tumour targeting while limiting damage to healthy tissue. Gold nanoparticles (AuNPs) and silver nanoparticle

SEP 17, 2026 · JOURNAL ARTICLE

Stimuli-Responsive Mesoporous Silica Nanoparticles for Precision Cancer Therapy: Design Principles, Cellular Uptake, and Translational Perspectives

Journal of Drug Targeting

:Premature drug release in the systemic circulation or at off-target sites remains a major challenge in conventional drug delivery systems, often resulting in reduced therapeutic e

SEP 5, 2026 · JOURNAL ARTICLE

Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy

Journal of Drug Targeting

Early-stage preclinical study in an animal model demonstrating formulation optimization and proof-of-concept for a nanocarrier delivery strategy; lacks human efficacy data and clinical outcomes.

AUG 17, 2026 · JOURNAL ARTICLE

Carrier-free nanoparticles for cancer therapy: assembly strategies, therapeutic applications, and clinical translation

Journal of Drug Targeting

This is a narrative review article synthesizing preclinical and early translational work on carrier-free nanoparticles; it raises questions and organizes the field rather than reporting original clinical trial data or definitive evidence.